Eli Lilly invests $3B to expand Wisconsin factory to help meet demand for Mounjaro, Zepbound

Eli Lilly is spending another $3 billion to bulk up manufacturing as the drugmaker seeks to stoke production of some blockbuster drugs and future products

Topics

Ro to offer lower-price vials of weight loss drug Zepbound by teaming up with Eli Lilly

It is made possible through a first-of-a-kind integration with Eli Lilly's direct-to-consumer website, and aims to streamline access to the popular treatment.
CNBC - 16h
Cardinals to explore trading All-Star 3B Arenado

The Cardinals' rebuilding plan includes potentially trading star third baseman Nolan Arenado.
ESPN - 1d
These tips for investing in mutual funds and ETFs help you ride a year-end rally

Bitcoin, small-caps, gold in focus, and the stock market looks for holiday cheer.
MarketWatch - 6d
Eli Lilly Chief Says He Will Fight for the FDA, Challenging RFK Jr.’s Stance

The health care giant’s David Ricks defended the agency’s role in reviewing data and ensuring drug safety.
The New York Times - Dec. 4
Eli Lilly's obesity drug beats rival in head-to-head trial — where Cramer sees shares going next

New trial data has cemented Club holding Eli Lilly's pole position in the highly competitive weight loss drug race.
CNBC - Dec. 4
Eli Lilly says Zepbound’s weight-loss results beat those of rival Wegovy

Zepbound helped patients lose more weight than a major rival in a head-to-head trial.
MarketWatch - Dec. 4
Eli Lilly's Zepbound causes greater weight loss than Novo Nordisk's Wegovy in head-to-head trial

Zepbound's greater weight loss is a huge advantage for Eli Lilly, which is competing with Novo Nordisk for a larger share of the weight loss drug market.
CNBC - Dec. 4
Goldin helps Michigan beat No. 11 Wisconsin 67-64 as Badgers take their 1st loss

Vladislav Goldin scored a career-high 24 points – including three straight baskets inside down the stretch – and Michigan defeated No. 11 Wisconsin 67-64 in the Big Ten opener for both teams
ABC News - Dec. 4
BlackRock expanding in private credit, buys HPS Investment Partners for $12 billion

The deal, which is expected to close in mid-2025, comes during a boom for the private credit space.
CNBC - Dec. 3

Eli Lilly invests $3B to expand Wisconsin factory to help meet demand for Mounjaro, Zepbound

Topics

Related

Ro to offer lower-price vials of weight loss drug Zepbound by teaming up with Eli Lilly

Cardinals to explore trading All-Star 3B Arenado

These tips for investing in mutual funds and ETFs help you ride a year-end rally

Eli Lilly Chief Says He Will Fight for the FDA, Challenging RFK Jr.’s Stance

Eli Lilly's obesity drug beats rival in head-to-head trial — where Cramer sees shares going next

Eli Lilly says Zepbound’s weight-loss results beat those of rival Wegovy

Eli Lilly's Zepbound causes greater weight loss than Novo Nordisk's Wegovy in head-to-head trial

Goldin helps Michigan beat No. 11 Wisconsin 67-64 as Badgers take their 1st loss

BlackRock expanding in private credit, buys HPS Investment Partners for $12 billion

More from ABC News

Arizona AG sues Saudi firm over 'excessive' groundwater pumping, saying it's a public nuisance

Biden says healthy women help US prosperity as he highlights White House initiative on their health

In Nigeria's lithium boom, many mines are illegal and children do much of the work

Montana Supreme Court upholds lower court ruling that allows gender-affirming care for minors

NYPD commissioner says gun found on suspect in UnitedHealthcare CEO killing matches shell casings found at crime scene